A medication commonly used to treat non-small cell lung cancer that has spread, or metastasized, may have benefits for patients
Continue reading »
mypharmacynews.com
A medication commonly used to treat non-small cell lung cancer that has spread, or metastasized, may have benefits for patients
Continue reading »TUESDAY, Feb. 25, 2020 — By the time he was 7 months old, John Michael Crawford had been diagnosed with
Continue reading »The human immune system uses two pre-programmed strategies to tackle infection. One is fever, a resistance mechanism that tries to
Continue reading »Patients with terminal breast cancer could live for up to FIVE MONTHS longer by taking a cocktail of three drugs,
Continue reading »Patients with nonalcoholic steatohepatitis (NASH), a chronic liver disease and a leading cause for liver transplantation in the U.S., currently
Continue reading »A research team assessed the safety of conditionally immortalized proximal tubule epithelial cells for bioartificial kidney application, by using in
Continue reading »Based on scientific findings of the Netherlands Cancer Institute, a new combination treatment has been developed for patients with metastatic
Continue reading »Every year, approximately 17,000 new cases of spinal cord injury are reported in the United States. Recovering from an SCI
Continue reading »I am watching 15-year-old Seamus* step into a small arena and come face to face with a powerful chestnut stallion
Continue reading »Combining the PD-1 immune check point inhibitor nivolumab with the monoclonal antibody ipilimumab showed a consistent safety profile in special
Continue reading »